Why it was recalled
Presence of Foreign Substance
Product description
Furosemide Tablets, USP 40 mg, 1,000 Tablets, Rx Only, Manufactured for: Rising Pharmaceuticals Inc., East Brunswick, NJ 08816, Manufactured by: Graviti Pharmaceuticals Pvt. Ltd. Telangana - 502307, India, NDC 64980-563-10.
Lot numbers, UPCs & expiration codes
Lot# FUB125042G; Exp. 05/13/2027
Where it was sold
U.S. Nationwide
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0293-2026
- Classification
- Class II
- Status
- Ongoing
- Recall initiated
- Jan 10, 2026
- FDA report date
- Jan 28, 2026
- Quantity
- 4212 bottles
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Graviti Pharmaceuticals Private Limited
Original FDA data
Every field from FDA enforcement report D-0293-2026, exactly as published.
Show all FDA fields
- City
- Hyderabad
- Status
- Ongoing
- Country
- India
- Event ID
- 98289
- Address
- E & 621 Patancheru Mandal
- Address (line 2)
- Isnapur Village Rd; Survey No 621
- Code information
- Lot# FUB125042G; Exp. 05/13/2027
- Report date
- Jan 28, 2026
- Product type
- Drugs
- Recall number
- D-0293-2026
- Classification
- Class II
- Recalling firm
- Graviti Pharmaceuticals Private Limited
- Product quantity
- 4212 bottles
- Reason for recall
- Presence of Foreign Substance
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Furosemide Tablets, USP 40 mg, 1,000 Tablets, Rx Only, Manufactured for: Rising Pharmaceuticals Inc., East Brunswick, NJ 08816, Manufactured by: Graviti Pharmaceuticals Pvt. Ltd. Telangana - 502307, India, NDC 64980-563-10.
- Distribution pattern
- U.S. Nationwide
- Recall initiation date
- Jan 10, 2026
- Initial firm notification
- Letter
- Center classification date
- Jan 21, 2026